Colonic transit influences deoxycholic acid kinetics

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 812-822

  Veysey, Martin J ^a,b   Thomas, Linzi A ^a,b   Mallet, Anthony I ^a,c   Jenkins, Paul J ^a,d   Besser, G Michael ^a,d   Murphy, Gerard M ^a,b   Dowling, R Hermon ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLIC ACID; DEOXYCHOLIC ACID; OCTREOTIDE;

ACROMEGALY; ADULT; AGED; ARTICLE; CHOLESTEROL STONE; CLINICAL ARTICLE; COLON; COLON ABSORPTION; CONSTIPATION; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE TRANSIT TIME; MALE; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034788295     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.28015     Document Type: Article

References (54)

1. Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study
2. Octreotide-associated biliary tract dysfunction and gallstone formation: Pathophysiology and management
3. Gallstones during octreotide therapy
4. The roles of gallbladder emptying and intestinal transit in the pathogenesis of octreotide-induced gallbladder stones
5. Postprandial gallbladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly
6. Post prandial gallbladder motility during long term treatment with the long-acting somatostatin analogue SMS 201-955 in acromegaly
7. Assessment of gallbladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly
8. The effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly
9. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones
10. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man
11. Effect of somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men
12. Effects of somatostatin analogue SMS 201-955 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man
13. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome
14. Prolonged large bowel transit increases serum deoxycholic acid - A risk factor for octreotide induced gallstones
15. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: Three inter-related factors
16. The effects of cisapride on gallbladder emptying, intestinal transit and serum deoxycholate: A prospective randomised, double-blind, placebo-controlled trial
17. The turnover of cholic acid in man
18. Bile salt metabolism in the new-born. Measurement of pool size and synthesis by stable isotope technique
19. 13C-labeled bile acids
20. Acromegaly
21. Irritable bowel syndrome: Guidelines for the diagnosis
22. Simplified assessment of segmental colonic transit
23. Investigation of small bowel transit time in man utilizing pulmonary hydrogen measurements
24. 13C] deoxycholic acid and serum sampling
25. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. IV. Description and validation of a multicompartment model
26. Deoxycholic acid metabolism in patients with adenomas
27. Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey
28. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile
29. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: Biliary enrichment biochemical response
30. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis
31. The fate of labelled bile salts introduced into the colon
32. Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins
33. 7α-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones
34. Disorders of bile acid metabolism in cholesterol gallstone disease
35. Long-term effects of cholecystectomy on bile acid metabolism
36. Regulation of bile acid synthesis
37. Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans
38. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in the liver, gallbladder emptying and small intestinal transit
39. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients
40. Fasting bile salt pool size and composition after ileal resection
41. Postprandial gallbladder motor function: Refilling and turnover of bile in health and cholelithiasis
42. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism
43. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis
44. Roles of colonic transit, bacteriology, bile acid metabolising enzymes and deoxycholic acid in the pathogenesis of gallstones and colorectal cancer in acromegalic patients before and during octreotide treatment
45. Role of intestinal transit in the pathogenesis of cholesterol gallstones
46. An explanation for gallstones in normal weight women: Slow intestinal transit
47. Gallstones in a community free of obesity but prone to slow intestinal transit
48. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors
49. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: Three inter-related factors
50. Can colonic bacterial metabolites predispose to cholesterol gallstones?
51. Cloning and sequencing of a bile acid-inducible operon from Eubacterium sp. Strain VPI 12708
52. Do colonic bacteria contribute to cholesterol gallstone formation? Effects of lactulose on bile
53. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans
54. Increasing butyrate concentration in the distal colon by accelerating intestinal transit